Cargando…

Editorial: Omics for the objective diagnosis and management of immune-mediated rheumatic diseases

Detalles Bibliográficos
Autores principales:	Fu, Tieh-Cheng, Kung, Yen-Ying, Lin, Jr-Rung, Chang, Ching-Mao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880463/ https://www.ncbi.nlm.nih.gov/pubmed/36714387 http://dx.doi.org/10.3389/fmed.2023.1127430

Ejemplares similares

Associations Between Sarcopenia, Heart Failure and Myocardial Infarction in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis
por: Chang, Ching-Mao, et al.
Publicado: (2022)

Editorial: Innovation in Rheumatic Diseases
por: Jacinto, Maria João, et al.
Publicado: (2022)

Editorial: Rheumatic Diseases and Infection
por: Dong, Lingli, et al.
Publicado: (2022)

Editorial: Comorbidity Burden in Rheumatic Diseases
por: Nikiphorou, Elena, et al.
Publicado: (2018)

Editorial: Nutrition and Metabolism in Rheumatic Diseases
por: Canhao, Helena, et al.
Publicado: (2019)

Editorial: Infection-Related Rheumatic Diseases
por: Thomas, Konstantinos, et al.
Publicado: (2021)

Editorial: Omics in respiratory virus infectious diseases: integrating multi-omics to reveal data characteristics and mechanisms for the diagnosis and treatment of disease
por: Wang, Xuerui, et al.
Publicado: (2023)

Editorial: Osteoporosis in Rheumatic Diseases, What's New?
por: Ruaro, Barbara, et al.
Publicado: (2021)

Editorial: Molecular markers in rheumatic diseases and their comorbidities
por: Vazquez-Del Mercado, Monica, et al.
Publicado: (2023)

New insights at the interface between leprosy and immune-mediated rheumatic diseases
por: Cruz, Vitor Alves, et al.
Publicado: (2023)

Editorial: Chronic rheumatic inflammatory conditions and cardiovascular health
por: Lo Gullo, Alberto, et al.
Publicado: (2022)

Editorial: Omics biomarkers in inflammatory ocular diseases
por: Ttakeuchi, Masaru, et al.
Publicado: (2022)

Editorial: Current omics-based approaches as tools for improving the understanding, diagnosis and management of inflammatory lung disease
por: Tejera, Paula, et al.
Publicado: (2023)

Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era
por: Di Sanzo, Lorenzo, et al.
Publicado: (2022)

Editorial: Psychological impact and quality of life in rheumatic and musculoskeletal diseases
por: Talarico, Rosaria, et al.
Publicado: (2023)

Editorial: Immune-mediated lung injury
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2022)

Editorial: Recent advances on omics and biomarkers research in renal transplantation
por: Ding, Xiaoming, et al.
Publicado: (2023)

Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases
por: Sambataro, Gianluca, et al.
Publicado: (2022)

Editorial: Novel biomarkers for clinical and molecular stratification of organ involvement in rheumatic diseases
por: Sun, Xiaolin, et al.
Publicado: (2023)

Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy
por: Shen, Pan, et al.
Publicado: (2021)

Editorial: Diagnosis and treatment of sarcoidosis
por: Zhou, Ying, et al.
Publicado: (2023)

Editorial: Computational and systematic analysis of multi-omics data for drug discovery and development
por: Guo, Shicheng, et al.
Publicado: (2023)

Editorial: Rheumatic fever: 21st century clinical and experimental insights
por: Nascimento, Bruno R., et al.
Publicado: (2023)

Acute Rheumatism and Pneumonia
Publicado: (1908)

Editorial: Identification of immune-related biomarkers for cancer diagnosis based on multi-omics data
por: Cheng, Liang, et al.
Publicado: (2022)

Coronavirus disease 2019 in patients with rheumatic immune-mediated diseases in a single University Hospital, matched case-control study and literature review
por: Martínez-López, David, et al.
Publicado: (2022)

Fluorescence optical imaging feature selection with machine learning for differential diagnosis of selected rheumatic diseases
por: Rothe, Felix, et al.
Publicado: (2023)

Immunomics in Pediatric Rheumatic Diseases
por: Tay, Shi Huan, et al.
Publicado: (2019)

IL-33 in Rheumatic Diseases
por: Dong, Yuanji, et al.
Publicado: (2021)

Editorial: “Nuclear medicine in cancer diagnosis”
por: Cicone, Francesco, et al.
Publicado: (2022)

Editorial: The role of omics characteristics in the diagnosis, treatment, and prognosis of autoimmune diseases
por: Wu, Qinglong, et al.
Publicado: (2022)

Editorial: The Role of Biomarkers in the Immunopathology and Diagnosis of Immune Exacerbations in Leprosy—New Frontiers to Manage This Neglected Disease
por: Antas, Paulo R. Z., et al.
Publicado: (2022)

Editorial: Impact of System Biology and Molecular Medicine on the Management of Complex Immune Mediated Respiratory Diseases
por: Cárdaba, Blanca, et al.
Publicado: (2021)

Rheumatic Fever and Rheumatic Heart Disease a Historical Perspective
por: Hajar, Rachel
Publicado: (2016)

NR4A1-3 nuclear receptor activity and immune cell dysregulation in rheumatic diseases
por: Murphy, Evelyn P., et al.
Publicado: (2022)

Editorial: Application of Omics Approaches to the Diagnosis of Genetic Neurological Disorders
por: Legati, Andrea, et al.
Publicado: (2021)

Editorial: Diagnosis, Treatment, and Prognosis of Viral Hepatitis
por: Wu, Jian, et al.
Publicado: (2022)

Editorial: Advances in the diagnosis and treatment in kidney transplantation
por: Eller, Kathrin, et al.
Publicado: (2022)

Editorial: Advances in brain tumors diagnosis and treatment
por: de Biase, Dario, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rgk6hsg33g2c0tvlb8p88fnbgi